ocu-mix, page-14

Rustyone - you make a great point! Alan told people privately that the Sanofi deal would send the stock price soaring. But it didn't. Why? Well, it seems all his vague speak had lead everyone to think Sanofi had been taking orders for stability testing, validation, etc. Oops. Turns out, none of that had been done. Today, we find ourselves a year or more away from regulatory application. My point is questions are often worth asking.